Turn Therapeutics (TTRX) EPS (Basic) (2024 - 2026)

Turn Therapeutics (TTRX) posted quarterly EPS (Basic) of -$0.11 for Q1 2026, down 402.38% year-over-year from $0.04 in Q1 2025, and down 1.08% quarter-over-quarter from -$0.11 in Q4 2025.

Turn Therapeutics (TTRX) EPS (Basic) (2024 - 2026) Analysis & Trends

Turn Therapeutics' EPS (Basic) history runs 3 years deep, the most recent figure standing at -$0.11 for Q1 2026.

  • In Q1 2026, EPS (Basic) fell 402.38% year-over-year to -$0.11; the TTM figure through Mar 2026 stood at -$0.48 (changed N/A YoY), while the FY2025 annual figure was -$0.5, down 136.77% from the prior year.
  • EPS (Basic) for Q1 2026 stood at -$0.11, down from -$0.11 in the prior quarter.
  • The five-year high for EPS (Basic) was -$0.02 in Q4 2024, with the low at -$0.27 in Q3 2025.
  • The 3-year median for EPS (Basic) is -$0.07 (2024), against an average of -$0.09.
  • The sharpest annual moves came in 2025 and 2026: EPS (Basic) slumped 603.48% in 2025, then slumped 402.38% in 2026.
  • Turn Therapeutics' EPS (Basic) stood at -$0.02 in 2024, then sank by 498.38% to -$0.11 in 2025, then decreased by 1.08% to -$0.11 in 2026.
  • Business Quant data shows TTRX's EPS (Basic) at -$0.11 in Q1 2026, -$0.11 in Q4 2025, and -$0.27 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 4.34
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 12.62
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 7.59
4 Revolution Medicines 43.64 Bn 43.64 Bn - -3.06
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.16
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 0.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.18
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.23
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -0.06
10 Turn Therapeutics 285.07 Mn 285.07 Mn - -0.41

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.41
Mar 31, 2026 -0.11
Dec 31, 2025 -0.11
Sep 30, 2025 -0.27
Mar 31, 2025 -0.02
Dec 31, 2024 -0.02
Sep 30, 2024 -0.04